Nanosphere Q1 Revenues Improve 38 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Nanosphere today reported a 38 percent jump in its first quarter revenues, but fell short of the consensus Wall Street estimates on the top and bottom lines.

For the three months ended March 31, Nanosphere said that revenues increased to $3.3 million from $2.4 million on 56 percent growth in consumables sales. The company failed to meet the average analyst estimate of $3.7 million.

It had 48 new placements of the Verigene System during the first quarter and reaffirmed prior guidance of 200 new placements for full-year 2014.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.